S754
P.8.b. Other topics (clinical)
References [1] Rodr´ıguez-Cano T., Beato-Fernandez L., Rojo-Moreno L., VazLeal F.J., 2014. The role of temperament and character in the outcome of depressive mood in eating disorders. Compr Psychiatry 55, 1130– 1136. [2] Klump K.L., Bulik C.M., Pollice C., Halmi K.A., Fichter M.M., Berrettini W.H., et al., 2000. Temperament and character in women with anorexia nervosa. J Nerv Ment Dis 188, 559–567. [3] Cloninger C.R., 1994. Temperament and personality. Curr Opin Neurobiol 4, 266–273. [4] Sullivan P.F., Bulik C.M., Carter F.A., Joyce P.R., 1994. Correlates of severity in bulimia nervosa. Int J Eat Disord 20, 239–251.
P.8.b.012 Internalized stigma of patients infected with human immunodeficiency virus M.M. Kırpınar1 ° , N. Yıldız1 , O.F. Demirel1 , P.B. Y¨uksel2 , I. Balcıo˘glu1 , B.S. Kocazeybek2 1 Istanbul University Cerrahpasa Faculty of Medicine Cerrahpasa Medical Faculty, Psychiatry, Istanbul, Turkey; 2 Istanbul University Cerrahpasa Faculty of Medicine Cerrahpasa Medical Faculty, Clinical Bacteriology and Microbiology, Istanbul, Turkey Background: The Human Immuodeficiency Virus (HIV) has provoqued negative personal and societal response since its recognition in 1981. Internalized stigma can be defined as ‘subjective process, embedded within a socio-cultural context, which may be characterized by negative feelings (about self), maladaptive behavior, identity transformation or stereotype endorsement resulting from an individual’s experiences, perceptions, or anticipation of negative social reaction on the basis of their health condition’ [1]. Although there are many studies about HIV stigma, internalized stigma is not studied well. In Turkey, as our knowledge, there is not any study reasearched about internalized stigma with Berger’s HIV Stigma Scale, a Likert-type, self-report scale [2]. We aimed to study perceived stigmatization of HIV(+) patients and its relation with anxiety and depression. Methods and Materials: The study was conducted by the departments of psychiatry and microbiology in Istanbul University, Cerrahpa¸sa Faculty of Medicine. Patients diagnosed with HIV(+) more than 6 months were included. After psychiatric examination, semi-structured socio-demografic form, HIV Stigma Scale, Beck Depression Scale and Beck Anxiety Scale was applied to the patients. SPSS programme was used for statistical analysis. All statistical analyses were performed using the IBM SPSS Statistics 22.0 package program. Data were expressed as frequencies, median, and mean ± standard deviation. Kolmogorov–Smirnov test was used to assess the data normality. Two-sided Mann–Whitney test was applied to compare the differences between groups for continuous variables. Spearman correlation co-efficent for ordinal sample analysis and Pearson correlation co-efficent for parametric sample analysis was used. The value of p < 0.05 denoted statistical significance. Results: Mean age of the study group was 34.2. Eighty percent (n: 24) of the study group was male, and twenty percent was female (n: 6). Mean age of diagnosis was 30.3. All of the participants were under antiretroviral treatment. Mean duration of treatment was 37.7 months. Of patients, the infection was transmitted sexually in 83.4% while rest of them did not have knowledge of transmission way. Half of the patients (n: 15) referred that they told about the infection with their partner. Total score of stigma scale and all sub-scores were positively correlated with Beck depression scores, also total Berger stigma score and three subscores were positively correlated with Beck anxiety scores (p < 0.05, for each).
Conclusion: The nature of this infection makes vulnerable to stigmatization. Therefore HIV testing by at-risk individuals can be delayed due to this entity and also nonadherence to a efficient medication, as a result of stigmatization, becomes another obstacle for both clinician and patient [3]. Infection and treatment themselves have neuropsychiatric effects that can be complicated with anxiety, depression or other psychiatric disorders [4]. Preliminary results of our study revealed that anxiety and depression scores of HIV(+) patients are correlated with self stigma. These results reveal not only the importance of psychosocial support but also necessity of a neuropsychiatric view for HIV(+) patients. Inevitably, more studies with a neuropsychiatric aspect are necessary for understanding body, mind and even spirit of an individual living with HIV infection. References [1] Livingston, J.D., Boyd, J.E., 2010. Correlates and consequences of internalized stigma for people living with mental illness: A systematic review and meta-analysis. Social Science & Medicine, 71, 2150–2161. [2] Berger, B.E., Carol E.F., Felissa R.L., 2001. Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Research in nursing & health 24.6, 518–529. [3] Stall, R., Hoff, C., Coates, T.J., Paul, J., Phillips, K.A., Ekstrand, M., Diaz, R., 1996. Decisions to get HIV tested and to accept antiretroviral therapies among gay/ bisexual men: implications for secondary prevention efforts. JAIDS Journal of Acquired Immune Deficiency Syndromes, 11(2), 151–160. [4] Castellon, S.A., Hinkin, C.H., Wood, S., Yarema, K.T., 1998. Apathy, depression, and cognitive performance in HIV-1 infection. The Journal of Neuropsychiatry and Clinical Neurosciences, 10(3), 320–329.
P.8.b.013 Psychopharmacological treatment of patients with delirium referred to a consultation-liaison psychiatry service R. S´anchez Gonz´alez1 ° , E. Baill`es L´azaro2 , A. Bastidas Salvad´o2 , L. Pintor P´erez2 1 Insitut de neuropsiquiatria i addiccions, Department of Psychiatry, Barcelona, Spain; 2 Institut de Neuroci`encies. Hospital Cl´ınic i Provincial de Barcelona. Institut d’Investigacions Biom`ediques August Pi i Sunyer IDIBAPS. Universitat de Barcelona., Consultation-Liaison Service. Department of Psychiatry., Barcelona, Spain Introduction: Delirium is a syndrome of neuropsychiatric signs and symptoms that can accompany virtually any serious medical condition. It is characterized by a disturbance of attention and awareness, as well as variety of other aspects of cognition that develops over a short period of time in response to another medical condition. The development of delirium involves the complex interrelationship between a vulnerable patient (one with predisposing factors) and exposure to precipitating factors or noxious insults [1]. It is an independent risk factor for increased morbidity and mortality and is associated with increased lengths of stay and costs of care [2]. Nonpharmacologic approaches to managing symptoms of delirium should be instituted in every patient and most of them also require a psychopharmacologic management [3]. Purpose: The main objective of this study is to describe the psychopharmacological treatment profile of a sample of inpatients with delirium, referred to the consultation-liaison psychiatry service of the University Clinical Hospital of Barcelona. Methods: Longitudinal observational and descriptive study, using a standardized computerized clinical database. We used a nonprobability sampling method, assessing adult patients with diagnosis of delirium according DSM-IV-TR, who were consecutively referred to our general hospital consultation-liaison